Product Program year 2020 Source: CMS Open Payments

Mamba

Device Catheters

Open in the dashboard

General payments

$10,418

379 payments

Research payments

$0

0 payments

Through program year 2020, $10,418 in general payments and $0 in research payments were reported against Mamba (Catheters).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $7,550 312
2019 General $2,868 67

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $10,418 379 payments
Top recipients General payments · program year 2020
  1. Suhail Dohad Interventional Cardiology · Beverly Hills, CA $237 3% · 6 payments
  2. James Boatman Cardiovascular Disease · Johnstown, PA $226 3% · 6 payments
  3. Raymond Yau Interventional Cardiology · Albuquerque, NM $195 3% · 4 payments
  4. Taishi Hirai Interventional Cardiology · Columbia, MO $185 2% · 3 payments
  5. Prasad Gunasekaran Interventional Cardiology · Kansas City, KS $181 2% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $4,506 62% · 110 practitioners
  2. Cardiovascular Disease Internal Medicine $2,323 32% · 70 practitioners
  3. Internal Medicine $157 2% · 3 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $107 1% · 6 practitioners
  5. Vascular Surgery Surgery $107 1% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $1,783 24% · 44 recipients
  2. Oklahoma $549 7% · 6 recipients
  3. Missouri $549 7% · 8 recipients
  4. New Mexico $529 7% · 11 recipients
  5. Ohio $424 6% · 7 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

379 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record